1. Homepage
  2. Equities
  3. Australia
  4. Australian Stock Exchange
  5. ALS Limited
  6. Summary
    ALQ   AU000000ALQ6

ALS LIMITED

(ALQ)
  Report
Delayed Australian Stock Exchange  -  05/20 02:10:08 am EDT
12.17 AUD   -0.73%
03/15ALS Places Aud 276 Million of Long-Term USPP Debt
CI
03/09Defense metals corp. continues to drill high grade at wicheeda with 3.23% total rare earth oxide over 162 metres, including 4.21% over 45 metres from surface
AQ
03/02UBS Adjusts ALS' Price Target to AU$13.30 From AU$13.50, Keeps at Neutral
MT
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Australian Stock Exchange
05/16/2022 05/17/2022 05/18/2022 05/19/2022 05/20/2022 Date
11.92(c) 12.03(c) 12.27(c) 12.26(c) 12.17(c) Last
499 073 866 907 869 496 2 150 239 604 699 Volume
-0.75% +0.92% +2.00% -0.08% -0.73% Change
More quotes
Estimated financial data (e)
Sales 2022 2 107 M 1 480 M 1 480 M
Net income 2022 217 M 152 M 152 M
Net Debt 2022 948 M 666 M 666 M
P/E ratio 2022 26,8x
Yield 2022 2,62%
Sales 2023 2 264 M 1 591 M 1 591 M
Net income 2023 282 M 198 M 198 M
Net Debt 2023 865 M 608 M 608 M
P/E ratio 2023 20,8x
Yield 2023 2,85%
Capitalization 5 886 M 4 136 M 4 136 M
EV / Sales 2022 3,24x
EV / Sales 2023 2,98x
Nbr of Employees -
Free-Float 97,1%
More Financials
Company
ALS Limited is an Australian-based company, which is engaged in providing laboratory testing, inspection, certification and verification solutions. The Company operates through three segments: Life Sciences, Commodities, and Industrial. Its Life Sciences segment provides analytical testing, sampling services and remote monitoring for the environmental, food, pharmaceutical, and consumer product markets. Its... 
More about the company
Ratings of ALS Limited
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
B+
More Ratings
All news about ALS LIMITED
03/15ALS Places Aud 276 Million of Long-Term USPP Debt
CI
03/09Defense metals corp. continues to drill high grade at wicheeda with 3.23% total rare ea..
AQ
03/02UBS Adjusts ALS' Price Target to AU$13.30 From AU$13.50, Keeps at Neutral
MT
02/23ALS : Ceasing to be a substantial holder from MUFG
PU
2021ALS : Becoming a substantial holder from MUFG
PU
2021Perenti Global Divests MinAnalytical Laboratory Services Australia for $31 Million
MT
2021ALS : Application for quotation of securities - ALQ
PU
2021ALS : Ceasing to be a substantial holder from MUFG
PU
2021ALS : Change in substantial holding from CBA
PU
2021ALS LIMITED : Ex-dividend day for interim dividend
FA
2021Australian Shares Extend Losses for Second Straight Day as Big Banks Drag
MT
2021TRANSCRIPT : ALS Limited, H1 2022 Earnings Call, Nov 17, 2021
CI
2021ALS' Net Profit Jumps Nearly 9% in Fiscal H1, Revenue, EPS Above Street Expectations
MT
2021ALS : Dividend/Distribution - ALQ
PU
2021ALS : Investor Presentation Half Year Results HY2022
PU
More news
News in other languages on ALS LIMITED
2021Perenti Global se sépare de MinAnalytical Laboratory Services Australia pour 31 million..
2021Les actions australiennes continuent de perdre du terrain pour la deuxième journée cons..
2021Le bénéfice net d'ALS bondit de près de 9 % au premier semestre de l'exercice, le chiff..
2021ALS Limited déclare un dividende intérimaire pour la période se terminant le 30 septemb..
2021ALS acquiert une participation de 49 % dans la société européenne d'essais pharmaceutiq..
More news
Analyst Recommendations on ALS LIMITED
More recommendations
Chart ALS LIMITED
Duration : Period :
ALS Limited Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ALS LIMITED
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 11
Last Close Price 12,17 AUD
Average target price 12,92 AUD
Spread / Average Target 6,18%
EPS Revisions
Managers and Directors
Raj Naran Deputy CEO & Group General Manager-Life Sciences
Luis Damasceno Chief Financial Officer
Bruce John Phillips Chairman
John Francis Mulcahy Independent Non-Executive Director
Charlie B. Sartain Independent Non-Executive Director
Sector and Competitors
1st jan.Capi. (M$)
ALS LIMITED-6.96%4 136
CINTAS CORPORATION-17.95%37 207
TELEPERFORMANCE SE-21.96%18 955
BUREAU VERITAS SA-9.36%12 629
EDENRED SE11.51%11 862
LG CORP.-6.06%10 454